Meta-analysis shows ACE inhibitors may yield better outcomes in diabetics

11/5/2013 | Healio (free registration)

A systematic review and meta-analysis of 63 randomized clinical trials examining diabetic patients and antihypertensive drugs that appeared in British Medical Journal found that ACE inhibitors may help patients with diabetes more than other antihypertensive drugs. Researchers noted that ACE inhibitors fared better than placebo in reducing creatinine doubling, while beta-blockers were associated with increased risk of death in patients with diabetes.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ